Course Director:
Anjana Pillai, MD and Carla Harmath, MD
Series date:
01/01/2026 - 2:30pm CST to 12/31/2026 - 3:30pm CST
Accreditation Statement
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Board of Surgery (ABS)
Successful completion of this CME activity enables the learner to earn credit toward the CME requirement(s) of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.
Description
Bringing together hepatologists, surgeons, medical oncologists, radiologists, pathologists, and other members of the multidisciplinary care team, this conference provides a collaborative forum to review challenging cases involving benign and malignant liver tumors. Participants integrate clinical, imaging, and pathologic findings, evaluate individualized treatment strategies, and apply current evidence to guide complex diagnostic and therapeutic decision-making. Through multidisciplinary case discussion and the exchange of specialty expertise, learners will strengthen their clinical judgment, enhance interdisciplinary collaboration, and improve the quality, coordination, and outcomes of care for patients with liver tumors.
Series location:
UCMC
Chicago, IL
60637
United States
See map: Google Maps
ACGME/ABMS Core Competencies:
Patient Care and Procedural Skills
Medical Knowledge
Practice-based Learning and Improvement
Interpersonal and Communication Skills
Systems-based Practice

Facebook
X
LinkedIn
Forward